Rchr
J-GLOBAL ID:201801008894439008   Update date: Oct. 02, 2022

Rahman Mohammad Sofiqur

Rahman Mohammad Sofiqur
Affiliation and department:
Job title: Assistant Professor
Other affiliations (1):
  • University of Asia Pacific  Assistant Professor
Homepage URL  (1): http://researchmap.jp/SofiqueRahman/
Research field  (3): Pharmaceuticals - analytical and physicochemistry ,  Pharmaceuticals - health and biochemistry ,  Pharmaceuticals - chemistry and drug development
Research keywords  (1): Pharmacy
Papers (15):
  • Mohammad Sofiqur Rahman, Naoko Yoshida, Hirohito Tsuboi, James Regun Karmoker, Nadia Kabir, Simon Schaefermann, Yoshio Akimoto, Mohiuddin Ahmed Bhuiyan, Md. Selim Reza, Kazuko Kimura. A comprehensive analysis of selected medicines collected from private drug outlets of Dhaka city, Bangladesh in a simple random survey. Scientific Reports. 2022. 12. 1. 234-234
  • Mohammad Sofiqur Rahman, Naoko Yoshida, Miho Hanafusa, Ayaka Matsuo, Shu Zhu, Yukiko Stub, Chisato Takahashi, Hirohito Tsuboi, Ryo Matsushita, Keiko Maekawa, et al. Screening and quantification of undeclared PGF2α analogs in eyelash-enhancing cosmetic serums using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2022. 219. 114940-114940
  • Mohammad Sofiqur Rahman, Naoko Yoshida, Hirohito Tsuboi, Yuichiro Ishii, Yoshio Akimoto, Kazuko Kimura. Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis. Scientific Reports. 2021. 11. 1
  • Mohammad Sofiqur Rahman, Naoko Yoshida, Hirohito Tsuboi, Erina Maeda, Andrea Vanessa Velasco Ibarra, Theingi Zin, Yoshio Akimoto, Tsuyoshi Tanimoto, Kazuko Kimura. Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites. BMC Pharmacology and Toxicology. 2021. 22. 1
  • Mirai Sakuda, Naoko Yoshida, Takashi Takaoka, Tomoko Sanada, Mohammad Sofiqur Rahman, Tsuyoshi Tanimoto, Theingi Zin, Kazuko Kimura. Substandard and Falsified Medicines in Myanmar. Pharmacy. 2020
more...
MISC (4):
Lectures and oral presentations  (4):
  • Public health concerns of substandard antidiabetic medicine: Quality estimation of pioglitazone by a cross-sectional survey
    (6th FIP Pharmaceutical Sciences World Congress 2017 2017)
  • Public health concerns of substandard antidiabetic medicine: Quality estimation of pioglitazone by a cross-sectional survey
    (Young Scientists Satellite Conference 2017, Uppsala, Sweden 2017)
  • Assessment of the Extent of counterfeit medicines in Mandalay, Myanmar
    (31st Annual Meeting of the Japan Association for International Health 2016)
  • An investigation of the status of counterfeit and substandard medicines in Myanmar 2014-quality estimation of Omeprazole and Donepezil
    (30th Japan Association for International Health Congress 2015)
Education (3):
  • 2014 - 2017 Kanazawa University Drug Management & Policy Pharmaceutical Sciences
  • 2012 - 2013 University of Asia Pacific Pharmacy Pharmaceutical Technology
  • 2008 - 2012 University of Asia Pacific Pharmacy Pharmacy
Professional career (1):
  • PhD (Kanazawa University)
Work history (2):
  • 2020/04 - 現在 Kanazawa University Medi-Quality Security Institute (MQS)
  • 2018/05 - 2020/03 Kanazawa University Medi-Quality Security Institute (MQS) Post-Doctoral Fellow
Awards (6):
  • 2018/09 - Kanazawa University Conference and Travel Grant Conference and Travel Grant
  • 2017/09 - Takeda Science Foundation Fellowship Postdoctoral Fellowship
  • 2017/05 - Kanazawa University Conference and Travel Grant Conference and Travel Grant
  • 2015/11 - Japan Association for International Health (JAIH) Best Presentation Best Poster Presentation Award
  • 2015/03 - Ministry of Health, Labour and Welfare (MHLW) Research Travel Grant Research Travel Grant
Show all
Association Membership(s) (2):
International Pharmaceutical Federation ,  JAPAN ASSOCIATION FOR INTERNATIONAL HEALTH
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page